


{"id":7723,"date":"2025-07-01T20:27:14","date_gmt":"2025-07-01T12:27:14","guid":{"rendered":"https:\/\/allcancer.com\/cancer\/chronic-lymphocytic-leukemia-cll-2\/"},"modified":"2025-07-02T13:01:15","modified_gmt":"2025-07-02T05:01:15","slug":"%e6%85%a2%e6%80%a7%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e7%99%bd%e8%a1%80%e7%97%85-cll-%e7%99%8c%e7%97%87%e9%a1%9e%e5%9e%8b","status":"publish","type":"cancer_type","link":"https:\/\/allcancer.com\/hk\/%e7%99%8c%e7%97%87\/%e6%85%a2%e6%80%a7%e6%b7%8b%e5%b7%b4%e7%b4%b0%e8%83%9e%e7%99%bd%e8%a1%80%e7%97%85-cll-%e7%99%8c%e7%97%87%e9%a1%9e%e5%9e%8b\/","title":{"rendered":"\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL)"},"content":{"rendered":"<h2 class=\"h2-cancertype\">\u4ec0\u9ebc\u662f <strong>\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL)<\/strong>?<\/h2>\n<p class=\"p-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u662f\u4e00\u7a2e\u5f71\u97ff\u8840\u6db2\u548c\u9aa8\u9ad3\u7684\u764c\u75c7\uff0c\u6703\u7522\u751f\u904e\u91cf\u7684\u7570\u5e38\u6dcb\u5df4\u7d30\u80de (\u767d\u8840\u7403\u7684\u4e00\u7a2e\u4e9e\u578b)\u3002\u9019\u4e9b\u764c\u8b8a\u7684\u6dcb\u5df4\u7d30\u80de\u6703\u6162\u6162\u7d2f\u7a4d\uff0c\u9010\u6f38\u5f71\u97ff\u8eab\u9ad4\u6709\u6548\u5c0d\u6297\u611f\u67d3\u7684\u80fd\u529b\u3002<\/p>\n<p class=\"p-cancertype\">\u5728\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u4e2d\u89c0\u5bdf\u5230\u6700\u986f\u8457\u7684\u4ee3\u8b1d\u7279\u5fb5\u5c31\u662f\u6c83\u4f2f\u683c\u6548\u61c9\u3002\u5728\u9019\u7a2e\u60c5\u6cc1\u4e0b\uff0c\u764c\u7d30\u80de\u6d88\u8017\u8461\u8404\u7cd6\u7684\u901f\u5ea6\u6bd4\u6b63\u5e38\u7d30\u80de\u9ad8\u51fa 200 \u500d\u3002\u9019\u7a2e\u73fe\u8c61\u6703\u5c0e\u81f4\u7d30\u80de\u5feb\u901f\u751f\u9577\u548c\u589e\u6b96\uff0c\u56e0\u6b64\u91dd\u5c0d\u6027\u65b0\u9673\u4ee3\u8b1d\u6cbb\u7642\u662f\u6700\u4f73\u7684\u6cbb\u7642\u65b9\u6cd5\u3002<\/p>\n<h3 class=\"h3-cancertype\">\u77ad\u89e3\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u751f\u7269\u5b78<\/h3>\n<p class=\"p-cancertype\">\u5728\u6b63\u5e38\u60c5\u6cc1\u4e0b\uff0c\u6dcb\u5df4\u7d30\u80de\u6709\u52a9\u65bc\u5c0d\u6297\u611f\u67d3\u548c\u589e\u5f37\u514d\u75ab\u529b\u3002\u7136\u800c\uff0c\u5728\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u60c5\u6cc1\u4e0b\uff0c\u9019\u4e9b\u60e1\u6027\u6dcb\u5df4\u7d30\u80de\u6703\u5931\u53bb\u529f\u80fd\uff0c\u4e26\u958b\u59cb\u4e0d\u53d7\u63a7\u5236\u5730\u7d2f\u7a4d\u3002\u56e0\u6b64\uff0c\u7531\u65bc\u8840\u6db2\u548c\u9aa8\u9ad3\u4e2d\u7684\u7a7a\u9593\u548c\u8cc7\u6e90\u6709\u9650\uff0c\u5065\u5eb7\u7684\u7d05\u8840\u7403\u3001\u8840\u5c0f\u677f\u548c\u5176\u4ed6\u767d\u8840\u7403\u5c31\u6703\u8655\u65bc\u52a3\u52e2\u3002<\/p>\n<ul class=\"p-cancertype\">\n<li>\u5feb\u901f\u7684\u8461\u8404\u7cd6\u651d\u53d6\u548c\u65b0\u9673\u4ee3\u8b1d\u53ef\u70ba CLL \u764c\u7d30\u80de\u63d0\u4f9b\u80fd\u91cf\uff08\u6c83\u4f2f\u683c\u6548\u61c9\uff09\u3002<\/li>\n<li>\u4e0d\u53d7\u9650\u5236\u7684\u8907\u88fd\u6703\u5c0e\u81f4\u9aa8\u9ad3\u548c\u6dcb\u5df4\u7d44\u7e54\u904e\u5ea6\u64c1\u64e0\u3002<\/li>\n<li>\u529f\u80fd\u6027\u514d\u75ab\u53cd\u61c9\u6703\u6e1b\u5f31\uff0c\u589e\u52a0\u611f\u67d3\u7684\u53ef\u80fd\u6027\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u6d41\u884c\u75c5\u5b78\u548c\u5340\u57df\u8da8\u52e2<\/h3>\n<p class=\"p-cancertype\">\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u5c0d\u767d\u8840\u75c5\u7684\u8ca0\u64d4\u6709\u91cd\u5927\u5f71\u97ff\uff0c\u5c24\u5176\u662f\u5c0d\u5e74\u9577\u8005\u800c\u8a00\u3002\u6839\u64da WHO 2024 \u5e74\u6307\u5357\uff0c\u5168\u7403\u6bcf\u5e74\u7d04\u6709 21,000 \u500b\u65b0\u8a3a\u65b7\u75c5\u4f8b\u3002\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5\u4e3b\u8981\u5f71\u97ff 60 \u6b72\u4ee5\u4e0a\u7684\u6210\u5e74\u4eba\uff0c\u96a8\u8457\u5e74\u9f61\u589e\u9577\uff0c\u767c\u75c5\u7387\u4e5f\u9010\u6f38\u4e0a\u5347\uff0c\u5f88\u5c11\u51fa\u73fe\u5728\u5e74\u8f15\u4eba\u6216\u5152\u7ae5\u8eab\u4e0a\u3002<\/p>\n<p class=\"p-cancertype\">\u5728\u5305\u62ec\u9999\u6e2f\u5728\u5167\u7684\u4e9e\u6d32\u5730\u5340\uff0cCLL \u7684\u767c\u75c5\u7387\u76f8\u5c0d\u4f4e\u65bc\u897f\u65b9\u570b\u5bb6\uff1b\u7136\u800c\uff0c\u8fd1\u5e74\u4f86\u7684\u6578\u64da\u986f\u793a\uff0c\u8001\u5e74\u4eba\u7684\u767c\u75c5\u7387\u6709\u5fae\u5999\u7684\u4e0a\u5347\u8da8\u52e2\uff0c\u9019\u5f37\u8abf\u4e86\u8d8a\u4f86\u8d8a\u9700\u8981\u63d0\u9ad8\u8b66\u89ba\uff0c\u5c24\u5176\u662f\u96a8\u8457\u4e9e\u6d32\u4eba\u53e3\u5feb\u901f\u8001\u5316\u3002<\/p>\n<ul class=\"p-cancertype\">\n<li>\u8207\u5973\u6027\u76f8\u6bd4\uff0c\u7537\u6027\u7684\u767c\u75c5\u7387\u8f03\u9ad8\uff08\u7537\u5973\u6bd4\u4f8b\u7d04\u70ba 2:1\uff09\u3002<\/li>\n<li>\u4e3b\u8981\u5f71\u97ff\u5e74\u9577\u65cf\u7fa4\uff0c\u7279\u5225\u662f 60 \u6b72\u4ee5\u4e0a\u7684\u4eba\u3002<\/li>\n<li>\u75c5\u4f8b\u589e\u52a0\u8207\u4e9e\u6d32\u5404\u5730\uff08\u5c24\u5176\u662f\u9999\u6e2f\uff09\u4e2d\u4f4d\u5e74\u9f61\u8f03\u9ad8\u53ca\u4eba\u53e3\u8001\u5316\u6709\u95dc\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">CLL \u5c0d\u60c5\u7dd2\u548c\u8eab\u9ad4\u7684\u5f71\u97ff<\/h3>\n<p class=\"p-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u6703\u9010\u6f38\u51fa\u73fe\u75c7\u72c0\uff0c\u6700\u521d\u5f80\u5f80\u4e0d\u70ba\u4eba\u5bdf\u89ba\u3002\u96a8\u8457\u6642\u9593\u7684\u63a8\u79fb\uff0c\u60a3\u8005\u901a\u5e38\u6703\u51fa\u73fe\u4ee5\u4e0b\u75c7\u72c0<\/p>\n<ul class=\"p-cancertype\">\n<li>\u6301\u7e8c\u75b2\u52de\u6216\u7cbe\u75b2\u529b\u7aed<\/li>\n<li>\u6dcb\u5df4\u7d50\u816b\u5927\uff08\u6dcb\u5df4\u817a\u75c5\uff09\uff0c\u901a\u5e38\u7121\u75db\u4f46\u660e\u986f<\/li>\n<li>\u56e0\u514d\u75ab\u529b\u4e0b\u964d\u800c\u53cd\u8986\u611f\u67d3<\/li>\n<li>\u9ad4\u91cd\u4e0b\u964d\u3001\u76dc\u6c57\u548c\u5076\u723e\u767c\u71d2<\/li>\n<li>\u8a3a\u65b7\u7684\u4e0d\u78ba\u5b9a\u6027\u548c\u9577\u671f\u7ba1\u7406\u7684\u6311\u6230\u6240\u9020\u6210\u7684\u60c5\u7dd2\u56f0\u64fe\u3001\u7126\u616e\u6216\u6182\u9b31<\/li>\n<\/ul>\n<p class=\"p-cancertype\">\u9019\u4e9b\u5f71\u97ff\u7a81\u986f\u4e86\u611f\u540c\u8eab\u53d7\u7684\u81e8\u5e8a\u652f\u63f4\u3001\u5c0d\u75c5\u60a3\u53cb\u5584\u7684\u6cbb\u7642\u65b9\u6848\u4ee5\u53ca\u5fc3\u7406\u5e72\u9810\u7684\u91cd\u8981\u6027\u3002<\/p>\n<p class=\"p-cancertype\">\u8acb\u9020\u8a2a\u6211\u5011\u7684 <a href=\"\/hk\/cancer-biology\/\" title=\"\u764c\u75c7\u751f\u7269\u5b78\u8207\u65b0\u9673\u4ee3\u8b1d\">\u764c\u75c7\u751f\u7269\u5b78\u8207\u65b0\u9673\u4ee3\u8b1d<\/a> \u6559\u80b2\u9801\u9762\uff0c\u6216\u5728\u4ee5\u4e0b\u7db2\u5740\u63a2\u7d22\u6211\u5011\u7684\u5275\u65b0\u8a3a\u65b7\u89e3\u6c7a\u65b9\u6848 <a href=\"\/hk\/diagnostics\/\" title=\"\u5148\u9032\u7684\u764c\u75c7\u8a3a\u65b7\">\u8a3a\u65b7\u4e2d\u5fc3<\/a>.<\/p>\n<h2 class=\"h2-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u6210\u56e0\u8207\u98a8\u96aa\u56e0\u7d20<\/h2>\n<h3 class=\"h3-cancertype\">\u8207 CLL \u76f8\u95dc\u7684\u907a\u50b3\u548c\u5206\u5b50\u56e0\u7d20<\/h3>\n<p class=\"p-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u5df2\u767c\u73fe\u591a\u7a2e\u57fa\u56e0\u7a81\u8b8a\u548c\u67d3\u8272\u9ad4\u8b8a\u7570\u3002\u503c\u5f97\u6ce8\u610f\u7684\u907a\u50b3\u6a19\u8a18\u5305\u62ec<\/p>\n<ul class=\"p-cancertype\">\n<li>13q \u67d3\u8272\u9ad4\u7f3a\u5931\uff08\u901a\u5e38\u8207\u75be\u75c5\u9032\u5c55\u8f03\u6162\u6709\u95dc\uff09\u3002<\/li>\n<li>\u67d3\u8272\u9ad4 17p \u7f3a\u5931 (\u5e38\u8207\u4fb5\u8972\u6027\u75be\u75c5\u6709\u95dc)\u3002<\/li>\n<li>TP53 \u57fa\u56e0\u7a81\u8b8a\uff0c\u8207\u8010\u85e5\u6027\u548c\u4e0d\u826f\u9810\u5f8c\u6709\u95dc\u3002<\/li>\n<li>IgVH \u57fa\u56e0\u7a81\u8b8a\u986f\u793a\u75be\u75c5\u767c\u5c55\u7684\u9810\u5f8c\u5dee\u7570\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u4ee3\u8b1d\u8106\u5f31\u6027\u8207\u6cbb\u7642\u6a5f\u6703<\/h3>\n<p class=\"p-cancertype\">\u764c\u7d30\u80de\u65b0\u9673\u4ee3\u8b1d\u7684\u4f9d\u8cf4\u6027\uff0c\u4f8b\u5982\u589e\u52a0\u5c0d\u8461\u8404\u7cd6\u3001\u6709\u6642\u662f\u7a40\u80fa\u65b0\u9673\u4ee3\u8b1d\u901a\u8def\u7684\u4f9d\u8cf4\uff0c\u4ee3\u8868\u4e86\u53ef\u91dd\u5c0d\u7684\u5f31\u9ede\u3002\u7d04\u6709 50% \u7684\u764c\u7d30\u80de\u660e\u986f\u4f9d\u8cf4\u7a40\u80fa\u4f86\u5408\u6210\u6838\u82f7\u9178\uff1a<\/p>\n<ul class=\"p-cancertype\">\n<li>\u91dd\u5c0d\u8461\u8404\u7cd6\u65b0\u9673\u4ee3\u8b1d\u901a\u8def (Warburg \u6548\u61c9) \u53ef\u4ee5\u74e6\u89e3\u764c\u7d30\u80de\u7684\u80fd\u91cf\u4f86\u6e90\u3002<\/li>\n<li>\u5728\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u6e1b\u5c11\u65b0\u9673\u4ee3\u8b1d\u71c3\u6599\u4f86\u6e90\u7684\u65b0\u9673\u4ee3\u8b1d\u7642\u6cd5\u5df2\u986f\u793a\u51fa\u53ef\u559c\u7684\u6210\u679c\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u74b0\u5883\u548c\u751f\u6d3b\u65b9\u5f0f\u98a8\u96aa\u56e0\u7d20<\/h3>\n<p class=\"p-cancertype\">\u8207\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u76f8\u95dc\u7684\u6f5b\u5728\u74b0\u5883\u56e0\u7d20\u5305\u62ec\u9577\u6642\u9593\u63a5\u89f8\u67d0\u4e9b\u5316\u5b78\u7269\u8cea\u548c\u8f3b\u5c04\u4f86\u6e90\uff1a<\/p>\n<ul class=\"p-cancertype\">\n<li>\u63a5\u89f8\u5316\u5b78\u7269\u8cea\uff08\u5982\u82ef\u3001\u8fb2\u696d\u6bba\u87f2\u5291\uff09\u3002<\/li>\n<li>\u96fb\u96e2\u8f3b\u5c04\u3002<\/li>\n<li>\u751f\u6d3b\u578b\u614b\u56e0\u7d20 (\u4f8b\u5982\u9577\u671f\u4f7f\u7528\u7159\u8349) \u53ef\u80fd\u6703\u7a0d\u5fae\u589e\u52a0\u7f79\u60a3 CLL \u7684\u98a8\u96aa\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u9999\u6e2f\u53ca\u4e9e\u6d32\u7684\u7279\u5b9a\u98a8\u96aa<\/h3>\n<p class=\"p-cancertype\">\u96d6\u7136\u6709\u95dc\u4e9e\u6d32\u7368\u7279\u98a8\u96aa\u7684\u8cc7\u6599\u6709\u9650\uff0c\u4f46\u4eba\u53e3\u8001\u5316\u9810\u6599\u6703\u5927\u5e45\u5f71\u97ff\u9999\u6e2f\u53ca\u9130\u8fd1\u5730\u5340\u7684\u767c\u75c5\u7387\u3002\u65e9\u671f\u7be9\u6aa2\u548c\u6700\u4f73\u7684\u9577\u8005\u7167\u8b77\u662f\u91cd\u8981\u7684\u9810\u9632\u7b56\u7565\u3002\u5728\u9999\u6e2f\uff0c\u8d8a\u4f86\u8d8a\u591a\u7684\u610f\u8b58\u548c\u9577\u8005\u793e\u5340\u6559\u80b2\u6d3b\u52d5\u5df2\u7d93\u8b49\u660e\u5728\u52a0\u5f37\u65e9\u671f\u6aa2\u6e2c\u65b9\u9762\u662f\u6709\u6548\u7684\u3002<\/p>\n<p class=\"p-cancertype\">\u63a2\u7d22\u6709\u95dc\u764c\u75c7\u9810\u9632\u548c\u65e9\u671f\u6aa2\u6e2c\u7684\u8a73\u7d30\u8cc7\u6e90\uff0c\u9019\u4e9b\u8cc7\u6e90\u4f86\u81ea\u503c\u5f97\u4fe1\u8cf4\u7684\u6b0a\u5a01\u6a5f\u69cb\uff0c\u4f8b\u5982 <a href=\"https:\/\/www.who.int\" title=\"\u4e16\u754c\u885b\u751f\u7d44\u7e54\" target=\"_blank\" rel=\"noopener\">\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO)<\/a> \u548c <a href=\"https:\/\/www.cancer.gov\" title=\"\u570b\u5bb6\u764c\u75c7\u7814\u7a76\u6240\" target=\"_blank\" rel=\"noopener\">\u570b\u5bb6\u764c\u75c7\u7814\u7a76\u6240<\/a>.<\/p>\n<p class=\"p-cancertype\">\u63a2\u7d22\u6211\u5011\u9769\u547d\u6027\u7684 4D \u4ee3\u8b1d\u7642\u6cd5\u5982\u4f55\u6539\u8b8a\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u6cbb\u7642\u3002\u7acb\u5373\u9810\u7d04\u8aee\u8a62\uff0c\u5411\u5148\u9032\u4ee3\u8b1d\u764c\u75c7\u7167\u8b77\u9081\u51fa\u7b2c\u4e00\u6b65\u3002<\/p>\n<h2 class=\"h2-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u75c7\u72c0<\/h2>\n<p class=\"p-cancertype\">\u8a8d\u8b58 <strong>\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u65e9\u671f\u75c7\u72c0<\/strong> \u6703\u56b4\u91cd\u5f71\u97ff\u6cbb\u7642\u7d50\u679c\u548c\u6210\u529f\u7387\u3002\u5982\u679c\u9019\u4e9b\u75c7\u72c0\u6301\u7e8c\u5b58\u5728\uff0c\u5c31\u5fc5\u9808\u53ca\u6642\u5c31\u91ab\u8a55\u4f30\uff1a<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>\u75b2\u52de\uff1a<\/strong> \u7531\u65bc\u9aa8\u9ad3\u4e2d\u7684\u767d\u8840\u75c5\u7d30\u80de\u6ef2\u900f\u800c\u5f15\u8d77\u8ca7\u8840\uff0c\u5f71\u97ff\u7d05\u8840\u7403\u6578\u91cf\uff0c\u5c0e\u81f4\u6301\u7e8c\u6027\u75b2\u5026\u6216\u7cbe\u75b2\u529b\u7aed\u3002<\/li>\n<li><strong>\u6dcb\u5df4\u817a\u75c5\u8b8a\uff1a<\/strong> \u6dcb\u5df4\u7d50\u816b\u5927\uff0c\u6700\u5e38\u898b\u65bc\u9838\u90e8\u3001\u814b\u4e0b\u6216\u8179\u80a1\u6e9d\u5340\u57df\uff0c\u986f\u793a\u6dcb\u5df4\u7d30\u80de\u7a4d\u805a\u548c\u75be\u75c5\u60e1\u5316\u3002<\/li>\n<li><strong>\u7d93\u5e38\u611f\u67d3\uff1a<\/strong> \u60a3\u8005\u901a\u5e38\u6703\u7d93\u6b77\u53cd\u8986\u611f\u67d3\uff0c\u9019\u8207\u767d\u8840\u75c5\u7d30\u80de\u8d85\u8d8a\u6b63\u5e38\u767d\u8840\u7403\u5c0e\u81f4\u514d\u75ab\u529f\u80fd\u53d7\u640d\u6709\u95dc\u3002<\/li>\n<li><strong>\u591c\u9593\u51fa\u6c57\uff1a<\/strong> \u591c\u9593\u5927\u91cf\u51fa\u6c57\uff0c\u56b4\u91cd\u5f71\u97ff\u7761\u7720\u54c1\u8cea\uff0c\u901a\u5e38\u986f\u793a\u8207\u764c\u7d30\u80de\u6709\u95dc\u7684\u5168\u8eab\u6027\u767c\u708e\u548c\u4ee3\u8b1d\u4ea2\u9032\u3002<\/li>\n<li><strong>\u7121\u610f\u9593\u6e1b\u91cd\uff1a<\/strong> \u5728\u6c92\u6709\u6539\u8b8a\u98f2\u98df\u6216\u751f\u6d3b\u65b9\u5f0f\u7684\u60c5\u6cc1\u4e0b\u6e1b\u8f15\u9ad4\u91cd\uff0c\u9019\u662f\u6162\u6027\u60e1\u6027\u75be\u75c5\u5e38\u898b\u7684\u5168\u8eab\u6027\u6548\u61c9\uff0c\u539f\u56e0\u662f\u5206\u89e3\u4f5c\u7528\u589e\u52a0\u548c\u71df\u990a\u65b0\u9673\u4ee3\u8b1d\u6539\u8b8a\u3002<\/li>\n<li><strong>\u5bb9\u6613\u7600\u50b7\u6216\u51fa\u8840\uff1a<\/strong> \u7531\u65bc\u9aa8\u9ad3\u529f\u80fd\u75c5\u8b8a\u6240\u5c0e\u81f4\u7684\u8840\u5c0f\u677f\u7f3a\u4e4f\u75c7\uff0c\u53ef\u8868\u73fe\u70ba\u7d93\u5e38\u7600\u50b7\u3001\u8f15\u5fae\u50b7\u5bb3\u51fa\u8840\u904e\u591a\u6216\u81ea\u767c\u6027\u51fa\u8840\u767c\u4f5c\u3002<\/li>\n<li><strong>\u8179\u90e8\u4e0d\u9069\uff1a<\/strong> \u7531\u65bc\u767d\u8840\u75c5\u7d30\u80de\u6d78\u6f64\u9020\u6210\u813e\u5927\u6216\u809d\u5927\uff0c\u4f7f\u5668\u5b98\u529f\u80fd\u72f9\u7a84\uff0c\u5f15\u8d77\u8179\u58d3\u6216\u8179\u8139\u3002<\/li>\n<li><strong>\u84bc\u767d\uff1a<\/strong> \u76ae\u819a\u84bc\u767d\u53cd\u6620\u8ca7\u8840\u6216\u5e36\u6c27\u80fd\u529b\u4e0d\u8db3\uff0c\u8207\u764c\u75c7\u6dcb\u5df4\u7d30\u80de\u6291\u5236\u9aa8\u9ad3\u6709\u95dc\u3002<\/li>\n<li><strong>\u4f4e\u71d2\uff1a<\/strong> \u7121\u660e\u78ba\u611f\u67d3\u539f\u56e0\u7684\u767c\u71d2\u767c\u4f5c\u53ef\u80fd\u8868\u793a CLL \u5c0e\u81f4\u514d\u75ab\u7cfb\u7d71\u6539\u8b8a\u3002<\/li>\n<li><strong>\u547c\u5438\u6025\u4fc3\uff1a<\/strong> \u901a\u5e38\u662f\u7531\u65bc\u9aa8\u9ad3\u5167\u7684\u6ef2\u900f\u5f71\u97ff\u5230\u5e36\u6c27\u8840\u6db2\u6210\u5206\u800c\u5c0e\u81f4\u56b4\u91cd\u8ca7\u8840\u3002<\/li>\n<\/ul>\n<p class=\"p-cancertype\">\u65e9\u671f\u767c\u73fe\u75c7\u72c0\u662f\u6709\u6548\u6cbb\u7642\u7684\u95dc\u9375\uff0c\u56e0\u6b64\u5728\u65e9\u671f\u968e\u6bb5\u9032\u884c\u91ab\u7642\u8aee\u8a62\u53ef\u512a\u5316\u6cbb\u7642\u7684\u53ef\u80fd\u6027\uff0c\u4e26\u986f\u8457\u63d0\u9ad8\u75c5\u60a3\u7684\u5b58\u6d3b\u7387\u548c\u751f\u6d3b\u54c1\u8cea\u3002\u9069\u7528\u65bc\u9032\u968e\u8a3a\u65b7\u7a0b\u5e8f\u3001 <a href=\"\/hk\/diagnostics\/\" class=\"p-cancertype\">\u63a2\u7d22\u53ef\u7528\u8a3a\u65b7<\/a>.<\/p>\n<h2 class=\"h2-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u5206\u671f\u8207\u5b58\u6d3b\u7387<\/h2>\n<p class=\"p-cancertype\">\u77ad\u89e3 <strong>\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u5206\u671f<\/strong> \u9019\u6709\u52a9\u65bc\u60a3\u8005\u53ca\u5176\u5bb6\u5c6c\u77ad\u89e3\u9810\u671f\u7684\u9810\u5f8c\u60c5\u6cc1\uff0c\u4ee5\u53ca\u91dd\u5c0d\u75be\u75c5\u9032\u5c55\u7684\u53ef\u7528\u6cbb\u7642\u65b9\u6cd5\u3002\u4ee5\u4e0b\uff0c\u6211\u5011\u5c07\u8a73\u7d30\u4ecb\u7d39\u8207\u9999\u6e2f\u53ca\u4e9e\u6d32\u4eba\u53e3\u76f8\u95dc\u7684\u6bcf\u500b\u968e\u6bb5\u53ca\u5176\u76f8\u61c9\u7279\u5fb5\uff1a<\/p>\n<h3 class=\"h3-cancertype\">\u7b2c 1 \u671f - \u65e9\u671f\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL)<\/h3>\n<ul class=\"p-cancertype\">\n<li>\u7279\u5fb5\u70ba\u6dcb\u5df4\u7d30\u80de\u6578\u91cf\u589e\u52a0\uff0c\u4f46\u6dcb\u5df4\u7d50\u767c\u5927\u6700\u5c0f\u3002<\/li>\n<li>\u65e9\u671f CLL \u7684\u6cbb\u7642\u65b9\u5f0f\u53ef\u80fd\u662f\u89c0\u5bdf\u548c\u5b9a\u671f\u7be9\u6aa2 (\u89c0\u5bdf\u8207\u7b49\u5f85\u7684\u65b9\u5f0f)\uff0c\u4e0d\u904e\u4e5f\u53ef\u80fd\u6703\u7b56\u7565\u6027\u5730\u555f\u52d5\u7279\u5b9a\u7684\u4ecb\u5165\u7642\u6cd5\uff0c\u4f8b\u5982\u6eab\u548c\u5316\u7642\u3002<\/li>\n<li>\u4e9e\u6d32\u7279\u5225\u662f\u9999\u6e2f\u7684\u5b58\u6d3b\u7387\u986f\u793a\uff0c\u5728\u6b64\u968e\u6bb5\u7684\u5b58\u6d3b\u7387\u8d85\u904e 90% \u4e94\u5e74\uff0c\u9019\u8207\u53ca\u6642\u7684\u76e3\u6e2c\u548c\u6709\u6548\u7684\u65e9\u671f\u4ecb\u5165\u63aa\u65bd\u6709\u95dc\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u7b2c 2 \u671f - \u4e2d\u5ea6\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL)<\/h3>\n<ul class=\"p-cancertype\">\n<li>\u591a\u8655\u6dcb\u5df4\u7d50\u816b\u5927\u66f4\u70ba\u660e\u986f\uff0c\u6216\u813e\u81df\u548c\u809d\u81df\u8f15\u5fae\u816b\u5927\u3002<\/li>\n<li>\u53ef\u80fd\u6703\u51fa\u73fe\u5176\u4ed6\u5168\u8eab\u6027\u75c7\u72c0\uff0c\u53cd\u6620\u51fa\u7d2f\u7a4d\u7684\u767d\u8840\u75c5\u7d30\u80de\u8ca0\u8377\u3002<\/li>\n<li>\u6cbb\u7642\u7b56\u7565\u53ef\u80fd\u5305\u62ec\u9776\u5411\u7642\u6cd5\u3001\u55ae\u514b\u9686\u6297\u9ad4\u3001\u5316\u7642\u7d44\u5408\u6216\u65b0\u9673\u4ee3\u8b1d\u5e72\u9810\uff0c\u9019\u4e9b\u90fd\u662f\u57fa\u65bc\u674e\u570b\u83ef\u535a\u58eb\u548c\u5289\u570b\u9f8d\u6559\u6388\u7b49\u9802\u5c16\u816b\u7624\u5b78\u5bb6\u7684\u8afe\u8c9d\u723e\u734e\u652f\u6301\u7814\u7a76\u3002<\/li>\n<li>\u5728\u6b64\u968e\u6bb5\u7684\u60a3\u8005\u4e2d\uff0c\u7d04\u6709 70-85% \u7684\u60a3\u8005\u5728\u63a5\u53d7\u9069\u7576\u7684\u6cbb\u7642\u5f8c\uff0c\u53ef\u9054\u5230\u4e94\u5e74\u7684\u5b58\u6d3b\u7387\uff0c\u53cd\u6620\u51fa\u6162\u6027\u767d\u8840\u75c5\u60a3\u8005\u7167\u8b77\u7684\u91cd\u5927\u9032\u5c55\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u7b2c 3 \u671f - \u665a\u671f\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL)<\/h3>\n<ul class=\"p-cancertype\">\n<li>\u5728\u6b64\u968e\u6bb5\uff0c\u7531\u65bc\u767d\u8840\u75c5\u7d30\u80de\u5728\u9aa8\u9ad3\u4e2d\u7684\u6ef2\u900f\u7387\u8f03\u9ad8\uff0c\u5c0e\u81f4\u6b63\u5e38\u8840\u7d30\u80de\u88fd\u9020\u91cf\u6e1b\u5c11\uff0c\u56e0\u6b64\u60a3\u8005\u6703\u51fa\u73fe\u5927\u91cf\u6dcb\u5df4\u7d50\u816b\u5927\u548c\u8ca7\u8840\u3002<\/li>\n<li>\u5305\u62ec\u75b2\u52de\u3001\u611f\u67d3\u548c\u9ad4\u91cd\u4e0b\u964d\u7b49\u75c7\u72c0\u6703\u8b8a\u5f97\u66f4\u52a0\u8870\u5f31\u3002<\/li>\n<li>\u6cbb\u7642\u5305\u62ec\u7a4d\u6975\u7684\u591a\u6a21\u5f0f\u65b9\u6cd5 (\u4f8b\u5982\uff1a\u7d50\u5408\u5316\u5b78\u7642\u6cd5\u3001\u514d\u75ab\u7642\u6cd5\u548c\u65b0\u7684\u4ee3\u8b1d\u65b9\u6cd5)\uff0c\u76ee\u7684\u662f\u6e1b\u5c11\u5927\u91cf\u767d\u8840\u75c5\u7d30\u80de\u548c\u6539\u5584\u75c7\u72c0\u3002<\/li>\n<li>\u6301\u7e8c\u5b58\u6d3b\u7387\u5404\u6709\u4e0d\u540c\uff1b\u7d04\u6709 50% \u81f3 70% \u7684\u7b2c 3 \u671f\u75c5\u60a3\u53ef\u9054\u5230\u4e94\u5e74\u5b58\u6d3b\uff0c\u7a81\u986f\u51fa\u5168\u9762\u75be\u75c5\u7ba1\u7406\u7b56\u7565\u7684\u91cd\u8981\u6027\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u7b2c 4 \u671f - \u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u56b4\u91cd\u665a\u671f<\/h3>\n<ul class=\"p-cancertype\">\n<li>\u6700\u56b4\u91cd\u7684\u968e\u6bb5\uff0c\u5176\u7279\u5fb5\u70ba\u6dcb\u5df4\u7d30\u80de\u6578\u91cf\u6975\u9ad8\u3001\u56b4\u91cd\u8ca7\u8840\u3001\u8840\u5c0f\u677f\u6e1b\u5c11 (\u8840\u5c0f\u677f\u6578\u91cf\u4f4e)\u3001\u5ee3\u6cdb\u7684\u6dcb\u5df4\u817a\u75c5\u8b8a\uff0c\u4ee5\u53ca\u813e\u81df\u548c\u809d\u81df\u901a\u5e38\u56b4\u91cd\u816b\u5927\u3002<\/li>\n<li>\u8f49\u79fb\u6027\u6d78\u6f64\u53ef\u80fd\u767c\u751f\u5728\u91cd\u8981\u5668\u5b98\uff0c\u56b4\u91cd\u5f71\u97ff\u529f\u80fd\u548c\u751f\u6d3b\u54c1\u8cea\u3002<\/li>\n<li>\u7b2c 4 \u968e\u6bb5\u7684\u6cbb\u7642\u65b9\u6cd5\u7d50\u5408\u500b\u4eba\u5316\u7684\u5168\u8eab\u6027\u6cbb\u7642\uff0c\u5305\u62ec BTK \u6291\u5236\u5291\u7b49\u6a19\u9776\u6cbb\u7642\u3001\u55ae\u514b\u9686\u6297\u9ad4\uff0c\u4ee5\u53ca\u91dd\u5c0d\u8461\u8404\u7cd6\u651d\u53d6 (Warburg \u6548\u61c9) \u548c\u8c37\u6c28\u9170\u80fa\u4f9d\u8cf4\u6027\u7684\u5275\u65b0\u65b0\u9673\u4ee3\u8b1d\u6cbb\u7642\uff0c\u4ee5\u5229\u7528\u767d\u8840\u75c5\u7d30\u80de\u7684\u65b0\u9673\u4ee3\u8b1d\u5f31\u9ede\u3002<\/li>\n<li>\u60a3\u8005\u9762\u81e8\u6311\u6230\uff0c\u4f46\u8d8a\u4f86\u8d8a\u5148\u9032\u7684\u7642\u6cd5\uff0c\u5982\u7d93\u5168\u7403\u6b0a\u5a01\u6a5f\u69cb\uff08\u5982 FDA\u3001EMA\uff09\u9a57\u8b49\u3001MD Anderson \u548c\u6df1\u5733\u524d\u6d77\u6cf0\u5eb7\u5408\u4f5c\u5925\u4f34\u8a8d\u53ef\u7684\u7642\u6cd5\uff0c\u5728\u6162\u6027\u75be\u75c5\u7ba1\u7406\u65b9\u9762\u5c55\u73fe\u51fa\u4e86\u7a4d\u6975\u7684\u6210\u679c\u3002<\/li>\n<li>\u9999\u6e2f\u7684\u7d71\u8a08\u5206\u6790\u986f\u793a\uff0c3 \u81f3 5 \u5e74\u7684\u5e73\u5747\u5b58\u6d3b\u7387\u4ecb\u65bc 20% \u81f3 30% \u4e4b\u9593\uff0c\u53cd\u6620\u51fa\u76ee\u524d\u5728\u5275\u65b0\u6cbb\u7642\u548c\u500b\u4eba\u5316\u8b77\u7406\u65b9\u9762\u7684\u9032\u5c55\u3002<\/li>\n<\/ul>\n<p class=\"p-cancertype\">\u65e9\u671f\u4ecb\u5165\u80fd\u986f\u8457\u63d0\u5347\u5404\u968e\u6bb5\u7684\u7642\u6548\u3002AllCancer \u7684\u5c08\u6ce8\u7814\u7a76\u81f4\u529b\u65bc\u5728 2025 \u5e74\u524d\u5c07\u60e1\u6027\u816b\u7624\u8f49\u8b8a\u70ba\u53ef\u63a7\u5236\u7684\u6162\u6027\u75be\u75c5\uff0c\u4ee5\u5be6\u8b49\u548c\u540c\u7406\u5fc3\u70ba\u57fa\u790e\u7684\u7d9c\u5408\u6cbb\u7642\u7b56\u7565\uff0c\u5ef6\u9577\u512a\u8cea\u751f\u6d3b\u7684\u5e0c\u671b\u8207\u65e5\u4ff1\u589e\u3002\u8a0e\u8ad6\u53ef\u7528\u7684\u6cbb\u7642\u65b9\u6cd5\u3001 <a href=\"\/hk\/treatment-options\/\" class=\"p-cancertype\">\u700f\u89bd\u6211\u5011\u7684\u6cbb\u7642\u65b9\u6848\u9801\u9762<\/a>.<\/p>\n<h2 class=\"h2-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u6cbb\u7642\u65b9\u6848<\/h2>\n<p class=\"p-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u6cbb\u7642\u5728\u904e\u53bb\u5e7e\u5e74\u4f86\u6709\u4e86\u986f\u8457\u7684\u9032\u5c55\uff0c\u5927\u5e45\u6539\u5584\u4e86\u75c5\u60a3\u7684\u7642\u6548\u3002\u7136\u800c\uff0c\u6cbb\u7642\u65b9\u6cd5\u5728\u5f88\u5927\u7a0b\u5ea6\u4e0a\u53d6\u6c7a\u65bc\u6bcf\u4f4d\u60a3\u8005\u7684\u75be\u75c5\u968e\u6bb5\u3001\u907a\u50b3\u7279\u5fb5\u3001\u6574\u9ad4\u5065\u5eb7\u72c0\u6cc1\u4ee5\u53ca\u500b\u4eba\u504f\u597d\u3002\u5728\u6b64\uff0c\u6211\u5011\u5c07\u63a2\u8a0e\u76ee\u524d\u7684\u6a19\u6e96\u7642\u6cd5\uff0c\u4ee5\u53ca\u5728\u9999\u6e2f\u548c\u4e9e\u6d32\u986f\u793a\u51fa\u76f8\u7576\u6f5b\u529b\u7684\u65b0\u8208\u66ff\u4ee3\u7642\u6cd5\u3002<\/p>\n<h3 class=\"h3-cancertype\">\u6a19\u6e96\u5316\u5b78\u6cbb\u7642\u8207\u514d\u75ab\u6cbb\u7642<\/h3>\n<p class=\"p-cancertype\">\u5316\u5b78\u6cbb\u7642\u4ecd\u662f\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u57fa\u672c\u6cbb\u7642\u65b9\u5f0f\uff0c\u901a\u5e38\u4f7f\u7528\u6c1f\u9054\u62c9\u6ff1\u3001\u74b0\u78f7\u9178\u80fa\u548c\u5229\u59a5\u6614\u55ae\u6297 (FCR) \u7b49\u7d44\u5408\u3002<\/p>\n<ul class=\"p-cancertype\">\n<li>Fludarabine \u4e3b\u8981\u900f\u904e\u6291\u5236 DNA \u5408\u6210\uff0c\u8a98\u5c0e\u5feb\u901f\u589e\u6b96\u7684\u7d30\u80de\u51cb\u4ea1\u3002<\/li>\n<li>\u74b0\u78f7\u9170\u80fa\u662f\u53e6\u4e00\u7a2e\u5f37\u6548\u7684\u70f7\u5316\u5291\uff0c\u53ef\u7834\u58de DNA \u8907\u88fd\uff0c\u88dc\u5145\u6c1f\u9054\u62c9\u6ff1\u8a98\u767c\u7684\u7d30\u80de\u51cb\u4ea1\u3002<\/li>\n<li>\u5229\u59a5\u6614\u55ae\u6297\uff08Rituximab\uff09\u662f\u4e00\u7a2e\u91dd\u5c0d B \u7d30\u80de\u4e0a CD20 \u7684\u55ae\u682a\u6297\u9ad4\uff0c\u53ef\u5c07\u764c\u7d30\u80de\u6a19\u793a\u70ba\u514d\u75ab\u7cfb\u7d71\u7684\u7834\u58de\u76ee\u6a19\u3002<\/li>\n<\/ul>\n<p class=\"p-cancertype\">\u5728\u9999\u6e2f\u7684\u7b2c\u4e00\u7dda\u6cbb\u7642\u60a3\u8005\u4e2d\uff0c\u9019\u7a2e\u7d44\u5408\u65b9\u6848\u5df2\u8b49\u660e\u5177\u6709\u53ef\u89c0\u7684\u5b58\u6d3b\u7387\u548c\u8f03\u9ad8\u7684\u7642\u6548\u3002\u7136\u800c\uff0c\u60a3\u8005\u7684\u8010\u53d7\u6027\u548c\u7531\u6b64\u7522\u751f\u7684\u6bd2\u6027\u9700\u8981\u8b39\u614e\u8003\u616e\u3002<\/p>\n<h3 class=\"h3-cancertype\">CLL \u7ba1\u7406\u4e2d\u7684\u6a19\u9776\u6cbb\u7642<\/h3>\n<p class=\"p-cancertype\">\u9776\u5411\u7642\u6cd5\u5728\u6cbb\u7642 CLL \u65b9\u9762\u5927\u53d7\u6b61\u8fce\uff0c\u5b83\u4ee5\u66f4\u9ad8\u7684\u7cbe\u78ba\u5ea6\u5fb9\u5e95\u6539\u8b8a\u4e86\u6cbb\u7642\u5e72\u9810\uff0c\u540c\u6642\u5c07\u50b3\u7d71\u7642\u6cd5\u7684\u9644\u5e36\u50b7\u5bb3\u964d\u81f3\u6700\u4f4e\u3002\u4e3b\u8981\u7684\u6a19\u9776\u85e5\u7269\u5305\u62ec<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>Ibrutinib\uff1a<\/strong> \u64fe\u4e82 B \u7d30\u80de\u589e\u6b96\u4fe1\u865f\u901a\u8def\u7684 Bruton's \u916a\u6c28\u9178\u6fc0\u9176 (BTK) \u6291\u5236\u5291\u3002<\/li>\n<li><strong>Acalabrutinib\uff1a<\/strong> \u53e6\u4e00\u7a2e\u9078\u64c7\u6027 BTK \u6291\u5236\u5291\uff0c\u8207 ibrutinib \u76f8\u6bd4\uff0c\u8010\u53d7\u6027\u548c\u7279\u7570\u6027\u5747\u6709\u6240\u6539\u5584\uff0c\u53ef\u964d\u4f4e\u51fa\u8840\u548c\u5fc3\u81df\u75c5\u7684\u98a8\u96aa\u3002<\/li>\n<li><strong>Venetoclax\uff1a<\/strong> Venetoclax \u91dd\u5c0d\u963b\u6b62\u767d\u8840\u75c5\u7d30\u80de\u51cb\u4ea1\u7684 BCL-2 \u86cb\u767d\uff0c\u5373\u4f7f\u5c0d\u4e9e\u6d32\u60a3\u8005\u65cf\u7fa4\u7684\u8010\u85e5\u5fa9\u767c\u578b CLL \u4e5f\u986f\u793a\u51fa\u826f\u597d\u7684\u6548\u679c\u3002<\/li>\n<\/ul>\n<p class=\"p-cancertype\">\u6574\u5408 TP53 \u7b49\u7a81\u8b8a\u57fa\u56e0\u5256\u6790\u7684\u500b\u4eba\u5316\u65b9\u6cd5\uff0c\u8fd1\u5e74\u4f86\u5df2\u5927\u5e45\u63d0\u5347\u6a19\u9776\u6cbb\u7642\u7684\u6210\u679c\u3002<\/p>\n<h3 class=\"h3-cancertype\">\u5e79\u7d30\u80de\u79fb\u690d\u6cbb\u7642\u665a\u671f CLL<\/h3>\n<p class=\"p-cancertype\">\u540c\u7a2e\u7570\u9ad4\u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d (HSCT) \u53ea\u9069\u7528\u65bc\u7279\u5b9a\u7684\u665a\u671f\u6216\u9ad8\u907a\u50b3\u98a8\u96aa\u75c5\u60a3\uff0c\u5305\u62ec\u6350\u8d08\u5e79\u7d30\u80de\u53d6\u4ee3\u5bc6\u96c6\u5316\u7642\u5f8c\u7684\u75c5\u60a3\u9aa8\u9ad3\u3002<\/p>\n<ul class=\"p-cancertype\">\n<li>\u6b64\u7a0b\u5e8f\u53ef\u986f\u8457\u63d0\u9ad8\u9577\u671f\u7684\u7de9\u89e3\u7387\uff0c\u5c0d\u6a19\u6e96\u6cbb\u7642\u53cd\u61c9\u6709\u9650\u7684\u75c5\u60a3\u5c24\u5176\u6709\u5229\u3002<\/li>\n<li>\u7136\u800c\uff0c\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75be\u75c5 (GvHD) \u548c\u56b4\u91cd\u611f\u67d3\u7b49\u6f5b\u5728\u4f75\u767c\u75c7\u9700\u8981\u5c08\u696d\u3001\u7d93\u9a57\u8c50\u5bcc\u7684\u816b\u7624\u79d1\u5718\u968a\uff0c\u9019\u4e9b\u5718\u968a\u53ef\u5728\u9999\u6e2f\u7684\u5c08\u79d1\u4e2d\u5fc3\u627e\u5230\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u5275\u65b0\u4ee3\u8b1d\u6cbb\u7642<\/h3>\n<p class=\"p-cancertype\">\u764c\u7d30\u80de\u65b0\u9673\u4ee3\u8b1d\u7684\u8106\u5f31\u6027\u70ba\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u63d0\u4f9b\u4e86\u4ee4\u4eba\u632f\u596e\u7684\u6f5b\u5728\u6cbb\u7642\u76ee\u6a19\u3002<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>\u8461\u8404\u7cd6\u4ee3\u8b1d\u6291\u5236\uff1a<\/strong> \u91dd\u5c0d\u8461\u8404\u7cd6\u4ee3\u8b1d\u901a\u8def\uff08\u6c83\u4f2f\u683c\u6548\u61c9\uff09\u6703\u7834\u58de\u5c0d\u4fb5\u7565\u6027\u767d\u8840\u75c5\u7d30\u80de\u589e\u6b96\u81f3\u95dc\u91cd\u8981\u7684\u80fd\u91cf\u7522\u751f\u3002<\/li>\n<li><strong>GLUT \u8f6c\u8fd0\u4f53\u963b\u65ad\u5242\uff1a<\/strong> \u5c08\u9580\u963b\u65b7\u8461\u8404\u7cd6\u8f49\u904b\u86cb\u767d\uff08\u4e3b\u8981\u662f GLUT1\/GLUT3\uff09\u7684\u85e5\u7269\u53ef\u9078\u64c7\u6027\u5730\u4f7f\u764c\u7d30\u80de\u98e2\u9913\u800c\u4e0d\u6703\u5ee3\u6cdb\u5f71\u97ff\u6b63\u5e38\u7d30\u80de\uff0c\u56e0\u6b64\u986f\u793a\u51fa\u6f5b\u529b\u3002<\/li>\n<li><strong>\u8c37\u6c28\u9170\u80fa\u4ee3\u8b1d\u6291\u5236\u5291\uff1a<\/strong> \u764c\u7d30\u80de\u9ad8\u5ea6\u4f9d\u8cf4\u7a40\u80fa\u4ee3\u8b1d\uff0c\u4f7f\u5176\u6210\u70ba\u4ee5\u65b0\u9673\u4ee3\u8b1d\u4e2d\u65b7\u548c\u8a98\u5c0e\u7d30\u80de\u51cb\u4ea1\u70ba\u76ee\u6a19\u7684\u65b0\u578b\u6cbb\u7642\u7b56\u7565\u7684\u5438\u5f15\u7126\u9ede\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u500b\u4eba\u5316\u6cbb\u7642\u5728\u9999\u6e2f\u53ca\u4e9e\u6d32\u7684\u91cd\u8981\u6027<\/h3>\n<p class=\"p-cancertype\">\u7531\u65bc\u6cbb\u7642\u7d50\u679c\u6703\u56e0\u57fa\u56e0\u5716\u8b5c\u548c\u75c5\u4eba\u7684\u6574\u9ad4\u5065\u5eb7\u72c0\u6cc1\u800c\u6709\u986f\u8457\u7684\u5dee\u7570\uff0c\u9999\u6e2f\u7684\u91ab\u7642\u670d\u52d9\u63d0\u4f9b\u8005\u5f37\u8abf\u500b\u4eba\u5316\u91ab\u7642\u67b6\u69cb\u3002\u6839\u64da\u5ee3\u6cdb\u7684\u57fa\u56e0\u7d44\u5256\u6790\u548c\u9810\u671f\u7684\u6cbb\u7642\u7d50\u679c\u800c\u91cf\u8eab\u5b9a\u5236\u7684\u6cbb\u7642\u9078\u64c7\uff0c\u53ef\u986f\u8457\u512a\u5316\u5b58\u6d3b\u7387\u548c\u751f\u6d3b\u54c1\u8cea\u3002<\/p>\n<h2 class=\"h2-cancertype\">\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u50b3\u7d71\u7642\u6cd5\u7684\u9650\u5236<\/h2>\n<p class=\"p-cancertype\">\u5118\u7ba1\u6cbb\u7642\u6280\u8853\u65e5\u65b0\u6708\u7570\uff0c\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u6cbb\u7642\u4ecd\u9762\u81e8\u91cd\u5927\u6311\u6230\u3002\u50b3\u7d71\u7642\u6cd5\u96d6\u7136\u5f88\u6709\u50f9\u503c\uff0c\u4f46\u5f80\u5f80\u6709\u5176\u9650\u5236\u548c\u526f\u4f5c\u7528\uff0c\u5c0d\u75c5\u60a3\u7684\u7642\u6548\u548c\u751f\u6d3b\u54c1\u8cea\u9020\u6210\u8ca0\u9762\u5f71\u97ff\u3002<\/p>\n<h3 class=\"h3-cancertype\">\u5316\u7642\u7591\u96e3\u96dc\u75c7<\/h3>\n<p class=\"p-cancertype\">\u5316\u7642\u7642\u7a0b\uff08\u5982 FCR\uff09\u96d6\u7136\u5c0d\u8a31\u591a\u60a3\u8005\u521d\u671f\u6709\u6548\uff0c\u4f46\u526f\u4f5c\u7528\u5f88\u5927\uff0c\u53ef\u80fd\u6703\u9650\u5236\u5176\u9577\u671f\u4f7f\u7528\uff0c\u4e26\u5f71\u97ff\u9999\u6e2f\u4eba\u53e3\u7684\u751f\u6d3b\u54c1\u8cea\u3002<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>\u9aa8\u9ad3\u6291\u5236\uff1a<\/strong> \u8d85\u904e 70% \u7684\u75c5\u60a3\u514d\u75ab\u529f\u80fd\u6703\u986f\u8457\u4e0b\u964d\uff0c\u589e\u52a0\u611f\u67d3\u7684\u6a5f\u7387\uff0c\u5c0e\u81f4\u4f4f\u9662\u6642\u9593\u5ef6\u9577\u548c\u6cbb\u7642\u4e2d\u65b7\u3002<\/li>\n<li><strong>\u5fc3\u81df\u6bd2\u6027\uff1a<\/strong> \u7d04\u6709 23% \u4eba\u56e0\u84bd\u74b0\u985e\u5316\u7642\u800c\u767c\u751f\u5fc3\u81df\u4e0d\u826f\u4e8b\u4ef6\uff0c\u56b4\u91cd\u640d\u5bb3\u5fc3\u81df\u5065\u5eb7\u3002<\/li>\n<li><strong>\u7e7c\u767c\u6027\u764c\u75c7\uff1a<\/strong> \u6cbb\u7642\u76f8\u95dc\u764c\u75c7\u7684\u98a8\u96aa\u589e\u52a0 (\u9ad8\u9054 300%)\uff0c\u5c0d\u9577\u671f\u5b58\u6d3b\u8005\u7684\u7d50\u679c\u9020\u6210\u986f\u8457\u8ca0\u64d4\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u653e\u5c04\u6cbb\u7642\u76f8\u95dc\u7684\u4e0d\u826f\u53cd\u61c9<\/h3>\n<p class=\"p-cancertype\">\u5728\u6b98\u9918\u6dcb\u5df4\u817a\u75c5\u6216\u7de9\u89e3\u60c5\u6cc1\u4e0b\u9032\u884c\u7684\u653e\u5c04\u6cbb\u7642\uff0c\u4e5f\u6703\u5c0d\u9999\u6e2f\u60a3\u8005\u9020\u6210\u986f\u8457\u7684\u6f5b\u5728\u4e0d\u826f\u5f8c\u679c\uff1a<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>\u7d44\u7e54\u640d\u50b7\uff1a<\/strong> \u653e\u5c04\u6cbb\u7642\u7d93\u5e38\u6703\u9020\u6210\u5065\u5eb7\u7d44\u7e54\u53d7\u50b7\uff0c\u5f15\u8d77\u6162\u6027\u75bc\u75db\u3002<\/li>\n<li><strong>\u7e7c\u767c\u6027\u60e1\u6027\u816b\u7624\uff1a<\/strong> \u653e\u5c04\u5f8c\u7684\u7d30\u80de\u640d\u50b7\u53ef\u80fd\u6703\u589e\u52a0\u65e5\u5f8c\u7f79\u60a3\u7e7c\u767c\u6027\u764c\u75c7\u7684\u98a8\u96aa\uff0c\u4f7f\u75c5\u60a3\u7684\u9810\u5f8c\u60c5\u6cc1\u986f\u8457\u8907\u96dc\u5316\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u8207\u624b\u8853\u548c\u79fb\u690d\u7a0b\u5e8f\u76f8\u95dc\u7684\u9650\u5236<\/h3>\n<p class=\"p-cancertype\">\u6cbb\u7642 CLL \u4f75\u767c\u75c7\u7684\u624b\u8853\u65b9\u6cd5 (\u5982\u813e\u81df\u5207\u9664\u8853) \u6709\u5176\u56fa\u6709\u7684\u98a8\u96aa\uff0c\u5305\u62ec\uff1a<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>\u624b\u8853\u4f75\u767c\u75c7\uff1a<\/strong> \u5118\u7ba1\u91ab\u5b78\u767c\u5c55\u53ca\u570d\u8853\u671f\u6297\u751f\u7d20\u7684\u4f7f\u7528\uff0c\u624b\u8853\u5f8c\u611f\u67d3\u7684\u98a8\u96aa\u4ecd\u7136\u666e\u904d\u5b58\u5728\uff0c\u56b4\u91cd\u5ef6\u9072\u75c5\u60a3\u7684\u5fa9\u5065\u6642\u9593\u3002<\/li>\n<li><strong>\u9ad8\u5ea6\u4f9d\u8cf4\u6350\u6b3e\u8005\uff1a<\/strong> \u5e79\u7d30\u80de\u79fb\u690d\u53d7\u8005\u5728\u5f88\u5927\u7a0b\u5ea6\u4e0a\u53d6\u6c7a\u65bc\u6350\u8d08\u8005\u9aa8\u9ad3\u7684\u53ef\u7528\u6027\uff0c\u9019\u5728\u4e9e\u6d32\u5730\u5340\u5c24\u5176\u5177\u6709\u6311\u6230\u6027\u3002<\/li>\n<\/ul>\n<h3 class=\"h3-cancertype\">\u4ee3\u8b1d\u62b5\u6297\u8207\u75be\u75c5\u5fa9\u767c<\/h3>\n<p class=\"p-cancertype\">\u764c\u7d30\u80de\u7fa4\u7684\u6297\u85e5\u6a5f\u5236\u4f7f\u6cbb\u7642\u66f4\u52a0\u8907\u96dc\uff1a<\/p>\n<ul class=\"p-cancertype\">\n<li><strong>\u589e\u5f37 DNA \u4fee\u5fa9\u80fd\u529b\uff1a<\/strong> \u764c\u7d30\u80de\u5728 DNA \u4fee\u5fa9\u9175\u7d20\u904e\u7a0b\u4e2d\u986f\u793a\u51fa\u7d04 400% \u7684\u6d3b\u6027\u589e\u52a0\uff0c\u964d\u4f4e\u4e86\u57fa\u56e0\u6bd2\u6027\u7642\u6cd5\u7684\u6548\u679c\u3002<\/li>\n<li><strong>\u4ee3\u8b1d\u53ef\u5851\u6027\uff1a<\/strong> \u816b\u7624\u6703\u900f\u904e\u91cd\u65b0\u7de8\u6392\u65b0\u9673\u4ee3\u8b1d\u901a\u8def\u4f86\u5feb\u901f\u9069\u61c9\uff0c\u9650\u5236\u4e86\u5c0d\u50b3\u7d71\u6cbb\u7642\u7684\u6301\u7e8c\u53cd\u61c9\uff0c\u4e26\u51f8\u986f\u4e86\u5c0d\u5275\u65b0\u65b0\u9673\u4ee3\u8b1d\u6cbb\u7642\u65b9\u6cd5\u7684\u9700\u6c42\u3002<\/li>\n<\/ul>\n<p class=\"p-cancertype\">\u85c9\u7531\u8a8d\u8b58\u5230\u50b3\u7d71\u6cbb\u7642\u7684\u9650\u5236\uff0c\u4e26\u904b\u7528\u65b0\u9673\u4ee3\u8b1d\u764c\u7d30\u80de\u5f31\u9ede\u7684\u65b0\u77e5\u8b58\u4ee5\u53ca\u91dd\u5c0d\u6027\u6cbb\u7642\u7684\u5275\u65b0\uff0c\u5168\u9762\u7684 CLL \u7ba1\u7406\u9032\u5c55\u70ba\u6539\u5584\u75c5\u60a3\u7167\u8b77\u7d50\u679c\u63d0\u4f9b\u4e86\u91cd\u5927\u7684\u6a02\u89c0\u524d\u666f\uff0c\u5c24\u5176\u662f\u5728\u9999\u6e2f\u4ee5\u53ca\u66f4\u5ee3\u6cdb\u7684\u4e9e\u6d32\u7bc4\u570d\u5167\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>\u5728 AllCancer \u63a2\u7d22\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u767d\u8840\u75c5 (CLL) \u7684\u75c7\u72c0\u3001\u5206\u671f\u548c\u9769\u547d\u6027\u7684 HK \u4ee3\u8b1d\u7642\u6cd5\u3002<\/p>","protected":false},"author":3,"featured_media":7374,"parent":0,"menu_order":0,"template":"","class_list":["post-7723","cancer_type","type-cancer_type","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/allcancer.com\/hk\/wp-json\/wp\/v2\/cancer_type\/7723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allcancer.com\/hk\/wp-json\/wp\/v2\/cancer_type"}],"about":[{"href":"https:\/\/allcancer.com\/hk\/wp-json\/wp\/v2\/types\/cancer_type"}],"author":[{"embeddable":true,"href":"https:\/\/allcancer.com\/hk\/wp-json\/wp\/v2\/users\/3"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allcancer.com\/hk\/wp-json\/wp\/v2\/media\/7374"}],"wp:attachment":[{"href":"https:\/\/allcancer.com\/hk\/wp-json\/wp\/v2\/media?parent=7723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}